Your browser doesn't support javascript.
loading
Implications of metastatic stage at presentation in docetaxel naïve metastatic castrate resistant prostate cancer.
Roy, Soumyajit; Wallis, Christopher J D; Morgan, Scott C; Kishan, Amar U; Le, Amy Tu Trinh; Malone, Julia; Sun, Yilun; Spratt, Daniel E; Saad, Fred; Malone, Shawn.
Affiliation
  • Roy S; Department of Radiation Oncology, Rush University Medical Center, Chicago, Illinois, USA.
  • Wallis CJD; Department of Urology, Mount Sinai Hospital and University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Morgan SC; Division of Radiation Oncology, The Ottawa Hospital Cancer Centre, University of Ottawa, Ottawa, Ontario, Canada.
  • Kishan AU; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, California, USA.
  • Le ATT; Rush Medical College, Chicago, Illinois, USA.
  • Malone J; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Sun Y; Department of Population and Quantitative Health Sciences, School of Medicine, Case Western Reserve University, Cleveland, Ontario, USA.
  • Spratt DE; Department of Radiation Oncology, University Hospital Seidman Cancer Center, Case Western Reserve University, Cleveland, Ontario, USA.
  • Saad F; Department of Surgery, Université de Montréal, Montreal, Quebec, Canada.
  • Malone S; Division of Radiation Oncology, The Ottawa Hospital Cancer Centre, University of Ottawa, Ottawa, Ontario, Canada.
Prostate ; 83(10): 912-921, 2023 07.
Article in En | MEDLINE | ID: mdl-37071764

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms, Castration-Resistant Type of study: Clinical_trials Limits: Humans / Male Language: En Journal: Prostate Year: 2023 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms, Castration-Resistant Type of study: Clinical_trials Limits: Humans / Male Language: En Journal: Prostate Year: 2023 Type: Article Affiliation country: United States